75 results
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
the Board in its oversight of (i) the integrity of the Company’s financial statements, accounting and financial reporting processes, system … composed entirely of independent directors.
The Compensation Committee is responsible for assisting the Board in discharging its oversight
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
actors — so-called “majority of the minority” approval, and (iii) in certain instances, independent valuations and approval and oversight
6-K
EX-99.2
BLU
Bellus Health Inc
27 Apr 23
Material Change Report
6:04am
) and the Company exercises appropriate oversight of all Major Suppliers compliance with such Laws. The Company has not subjected any Major Suppliers
6-K
EX-99.2
BLU
Bellus Health Inc
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
of the current committees of the Board:
Audit Committee
The mandate of the Audit Committee includes assisting the Board in its oversight of (i) the integrity … .
The Compensation Committee is responsible for assisting the Board in discharging its oversight responsibilities relating to, among other things
6-K
EX-99.1
BLU
Bellus Health Inc
29 Mar 23
Current report (foreign)
5:26pm
of pharmaceutical products conducted by others may cause the FDA or other regulatory oversight bodies to suspend or terminate our clinical trials or to change … oversight by regulatory authorities and institutional review boards or ethics committees, and must meet the requirements of these authorities
SUPPL
fbraqy759oh3kz2kl
14 Nov 22
Supplemental materials (foreign)
5:25pm
6-K
EX-99.1
k4feb44ejj9irdu
14 Nov 22
Open Market Sale Agreementsm
5:19pm
F-10
1x7pj7ea
26 Aug 22
Registration of securities (Canada)
4:48pm
SUPPL
xi3 rc9c9jvjb
15 Jul 22
Supplemental materials (foreign)
7:01am
6-K
EX-99.2
haozseo9k
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
SUPPL
wqrobl6
13 Jul 22
Supplemental materials (foreign)
5:01pm
6-K
EX-99.2
0rt73ii1590edp
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
6-K
EX-99.1
b3xjyoli8z6dszyrg 7b
5 Apr 22
Current report (foreign)
4:07pm
40-F
EX-99.2
rav k9x3y
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.3
84qq0h rxii
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.1
cvn7korxlmp4hma8
23 Feb 22
Annual report (Canada)
5:20pm
6-K
EX-99.2
0s6voe27br32nk14
15 Dec 21
BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States
5:15pm
SUPPL
f2abj5aieyamx06y1d
15 Dec 21
Supplemental materials (foreign)
5:10pm
F-10
zedgu6i
14 Dec 21
Registration of securities (Canada)
9:43am
SUPPL
k7bztz4nl mrnulibfoh
13 Dec 21
Supplemental materials (foreign)
5:00pm